Enzyme Immunoassays for the Determination of Ovine LH and FSH
β Scribed by GM Peclaris; A Pappa; K Deligiannis; K Koutsotolis
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 117 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0936-6768
No coin nor oath required. For personal study only.
β¦ Synopsis
Contents
The development of competitive enzyme immunoassays for ovine plasma LH (oLH) and FSH (oFSH) is described. Standards and plasma samples were preincubated with diluted antiserum to oLH or oFSH and the reacted solution (100β__ΞΌ__l per well) was transferred to plates previously coated with oLH or oFSH, respectively. The second antibody used was antiβrabbit IgG horseradish peroxidase. The measuring range was 0.39β50βng/ml for each hormone and the 50% relative binding sensitivity was 9βng/ml for oLH. The respective value for oFSH was 3.5 or 34βng/ml with different hormone and antibody preparations used for the assay. The enzyme immunoassays were used to determine oLH and oFSH levels in plasma from ewes of two breeds during the oestrous cycle. The assays detected the first FSH surge coincident with the LH surge, the second FSH surge about 24βh later and the periodic fluctuations of FSH concentrations during the luteal phase of the oestrous cycle. These enzyme immunoassays are an efficient and economic alternative to the established radioimmunoassays (RIA) for oLH and oFSH.
π SIMILAR VOLUMES
TSH by the new assay and <0.1 mIU/L in the "TSHS" assay. This problematic group included a number of untreated Graves disease patients. This was a reproducible finding within samples and for the patient over time. Other patients who gave discordant TSH results with the new formulation included some
Despite the importance of Callitrichid primates in both biomedical and conservation research, practical and reliable immunoassays for the measurement of follicle-stimulating hormone (FSH) have not yet been described. A panel of monoclonal antibodies against specific peptide fragments within either t
## Abstract Metastin, a 54βresidue peptide, was identified as the cognate ligand of human Gβproteinβcoupled receptor GPR54. Since metastin is a gene product of the human metastasis suppressor gene β__KiSSβ1__β, early studies on metastin were focused on its activity as a tumor metastasis suppressor.